406 related articles for article (PubMed ID: 16552262)
1. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Kutler DI; Wong RJ; Schoder H; Kraus DH
Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging in head and neck cancer.
Kutler DI; Wong RJ; Kraus DH
Curr Oncol Rep; 2005 Mar; 7(2):137-44. PubMed ID: 15717948
[TBL] [Abstract][Full Text] [Related]
3. Positron-emission tomography for head and neck cancer.
Greven KM
Semin Radiat Oncol; 2004 Apr; 14(2):121-9. PubMed ID: 15095258
[TBL] [Abstract][Full Text] [Related]
4. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
Garcia C; Flamen P
Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626
[TBL] [Abstract][Full Text] [Related]
5. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
[TBL] [Abstract][Full Text] [Related]
8. Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
Goyal P; Hsu JM; Kellman RM
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):694-9. PubMed ID: 19128678
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
McCollum AD; Burrell SC; Haddad RI; Norris CM; Tishler RB; Case MA; Posner MR; Van den Abbeele AD
Head Neck; 2004 Oct; 26(10):890-6. PubMed ID: 15390197
[TBL] [Abstract][Full Text] [Related]
10. The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Prowse SJ; Shaw R; Ganeshan D; Prowse PM; Hanlon R; Lewis-Jones H; Wieshmann H
J Laryngol Otol; 2013 Aug; 127(8):780-7. PubMed ID: 23919968
[TBL] [Abstract][Full Text] [Related]
11. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
Paleri V; Zammit-Maempel I
J Clin Oncol; 2010 Oct; 28(28):e515. PubMed ID: 20606098
[No Abstract] [Full Text] [Related]
13. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
14. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in cancer of the head and neck.
Hain SF
Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
[TBL] [Abstract][Full Text] [Related]
16. Modern Radiology in the Management of Head and Neck Cancer.
Burkill GJ; Evans RM; Raman VV; Connor SE
Clin Oncol (R Coll Radiol); 2016 Jul; 28(7):440-50. PubMed ID: 27156741
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.
de Souza JA; Cohen EE
J Clin Oncol; 2010 Oct; 28(28):e516; author reply e517. PubMed ID: 20606097
[No Abstract] [Full Text] [Related]
18. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography in head and neck squamous cell carcinomas].
Conessa C; Clément P; Foehrenbach H; Poncet JL
Ann Otolaryngol Chir Cervicofac; 2006 Nov; 123(5):227-39. PubMed ID: 17185920
[TBL] [Abstract][Full Text] [Related]
20. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
